REGISTER HERE

Please join Pfizer Canada President, Najah Sampson and the IGNITE team as they share an overview of Pfizer’s new end-to-end offering for biotech partners. IGNITE leverages Pfizer’s resources, scale and expertise to amplify and accelerate innovation from pre-clinical R&D to through the development lifecycle. The presentation will include ample time for a robust Q&A.

ABOUT IGNITE:

The pandemic accelerated our recognition that many of today’s widespread and disruptive global healthcare challenges are too great for any one organization to tackle alone. They require innovation—and to be a true innovator, we believe you need to be a world-class collaborator.

Pfizer Ignite is rooted in a deep understanding of drug development and the unique challenges of biomedical innovation. The goal of Pfizer Ignite is to build foundational relationships with prospective biotech partners to help enhance the value of their program and accelerate bringing breakthrough therapies to patients.